VEGFA and diabetic retinopathy: Intravitreal (IVT) administration of anti-vascular endothelial growth factor (VEGF) therapy is currently the preferred treatment strategy for vascular retinal diseases, such as neovascular AMD (wet AMD), diabetic retinopathy, and diabetic macular edema.1